Double-Blind Prospective Randomized Comparison of Interferon Gamma-1b versus Placebo after Autologous Stem Cell Transplantation

Thirty-eight patients, including 14 with Hodgkin’s disease, 9 with non-Hodgkin’s lymphomas, 4 with multiple myeloma and 11 with solid tumors, were enrolled in our study. Between March 1995 and March 1